Evidence map›Paper›PMID 41691101›Full record

ArticleScientific reports2026

Clinically interpretable extracellular vesicle gene model for Non-Invasive liver cancer diagnosis.

Yan Zhang, Zhengying Mo, Lei Zhang, Zhangming Zhou, Zhaohan Wei, Yuan Zhu, Yadong Wang, Hu Wang, Debing Xiang, Jing Huang and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yan Zhang *Department of Clinical Laboratory Medicine, Jiangjin Hospital, Chongqing University, No. 725, Jiangzhou Avenue, Dingshan Subdistrict, Jiangjin District, Chongqing, China.
Zhengying Mo *Department of Oncology, Tai-He Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Lei Zhang *Department of Clinical Laboratory, Department of Clinical Laboratory, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Zhangming Zhou *Department of Neurosurgery, Dujiangyan Medical Center, Chengdu, China.
Zhaohan WeiMarshall Laboratory of Biomedical Engineering, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, International Cancer Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong, China.
Yuan ZhuLun Lun Research Institute of AI for Science, Beijing Diji Technology Co., Ltd, Beijing, China.
Yadong WangLun Lun Research Institute of AI for Science, Beijing Diji Technology Co., Ltd, Beijing, China.
Hu WangClinical Laboratory of Jingzhou Third People's Hospital, Jingzhou, Hubei, China.
Debing XiangDepartment of Oncology, Chongqing University Jiangjin Hospital, No. 725, Jiangzhou Avenue, Dingshan Subdistrict, Jiangjin District, Chongqing, China.
Jing HuangPediatrics Department, Chongqing University Jiangjin Hospital, Chongqing, China. 157265743@qq.com.
Qingle LiangDepartment of Clinical Laboratory Medicine, Jiangjin Hospital, Chongqing University, No. 725, Jiangzhou Avenue, Dingshan Subdistrict, Jiangjin District, Chongqing, China. liangqingle@126.com.

Funding

Development Program of Chongqing university, Jiangjin hospital 2023LJXM003,2024LJXM001Joint project of Chongqing Health Commission and Science and Technology Bureau 2025MSXM075Natural Science Foundation of Chongqing CSTB2024NSCQ-MSX0490Research Launch Project of Chongqing university, Jiangjin hospital 2023qdjfxm006Scientific and Technological Research Program of Chongqing Municipal Education Commission KJZD-M202300102
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide, underscoring the need for improved non-invasive diagnostic strategies. In this study, we developed an interpretable machine learning model using extracellular vesicle (EV)-derived RNA signatures from the exoRBase 3.0 database. Six machine learning algorithms were evaluated, among which a Deep Neural Network achieved numerically higher discriminative performance under the experimental setup used in this study (AUC = 0.8877) on an internal hold-out test set. A panel of ten diagnostic mRNAs (MTRNR2L8, HBB, PF4, FTL, MTRNR2L12, TMSB4X, PPBP, OST4, ACTB, and S100A9) were identified, with MTRNR2L8 showing the strongest contribution to model predictions. SHapley Additive exPlanations and Kolmogorov–Arnold Networks were applied to enhance interpretability and to characterize nonlinear relationships between EV-derived gene expression features and classification outcomes. An online prediction interface was implemented as a demonstration tool to illustrate potential applicability. Overall, this study presents an exploratory, proof-of-concept framework for EV-based HCC classification. Further validation in independent and prospective cohorts will be required before clinical application can be considered.

Indexed as

Biomarkers, TumorCarcinoma, HepatocellularExtracellular VesiclesLiver NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMachine LearningRNA, MessengerBiomarkers, TumorRNA, MessengerDiagnostic biomarkerExtracellular vesicleHepatocellular carcinomaInterpretabilityNon-invasive

Identifiers

PMID41691101
PMCPMC12992603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.